Announcements
WEBCAST: EXPLORING THE MECHANISMS OF ACTIVITY OF IMiD COMPOUNDS
The mechanisms of activity of immunomodulatory compounds and their emerging use in the treatment algorithms of various hematologic cancers is the focus of this fascinating program. From a satellite symposium at Lymphoma & Myeloma 2008 on October 17, 2008 in New York, New York. The faculty includes Morton Coleman, MD, Paul A. Hamlin, MD, and Jeffrey A. Zonder, MD.
Visit elc.imedex.com for a full menu of accredited activities on your own time.



